← Open Payments lookup

NINA BHARADWAJ: Open Payments

NPI 1790541001 · FLAGSTAFF, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,128 in 98 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $203 · 2025 $2,128

Food & beverage: $2,128
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP15$329
Regeneron Healthcare Solutions, Inc.15$293
Takeda Pharmaceuticals U.S.A., Inc.9$248
Genentech USA, Inc.8$218
GENZYME CORPORATION7$214
Novartis Pharmaceuticals Corporation10$165
LEO Pharma Inc.6$147
Azurity Pharmaceuticals, Inc.6$102
Amgen Inc.5$84
GlaxoSmithKline, LLC.3$62

Products named: DUPIXENT, Xolair, HYQVIA, TEZSPIRE, ADBRY, FASENRA, Rhapsido, ALVESCO.

Industry payments across AZ — which companies pay providers there.